Dr. LaRosa is an Infectious Disease and Internal Medicine Physician with nearly two decades of years of experience in direct patient care and clinical research in sepsis and severe infections. He has directed large Phase 2 and Phase 3 clinical trials in sepsis, and between 1998 and 2001 acted as the Lead Clinical Research Physician at Eli Lilly for the trial that led to the FDA and EMEA approval of Xigris for severe sepsis. He has hands-on experience in clinical development planning, protocol and case report form design, site selection and training, medical monitoring and data review. He has led numerous clinical evaluation committees, data safety monitoring boards and medical advisory boards. Additionally, he has been an advisor to venture capitalists and investors performing due diligence and market analysis in critical-care medicine.